Independent Advisor Alliance Merck & Co., Inc. Transaction History

Independent Advisor Alliance

$2.71 Billion
Q3 2024

A detailed history of Independent Advisor Alliance transactions in Merck & Co., Inc. stock. As of the latest transaction made, Independent Advisor Alliance holds 66,051 shares of MRK stock, worth $6.48 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

66,051

Previous 68,876 4.1%

Holding current value

$6.48 Million

Previous $8.53 Million 12.03%

% of portfolio

0.28%

Previous 0.3%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$111.15 - $128.97 $313,998 - $364,340	-2,825 Reduced 4.1%	66,051 $7.5 Million
Q2 2024 Aug 12, 2024	BUY	$123.8 - $132.96 $132,466 - $142,267	1,070 Added 1.58%	68,876 $8.53 Million
Q1 2024 May 08, 2024	BUY	$113.24 - $131.95 $400,190 - $466,311	3,534 Added 5.5%	67,806 $8.95 Million
Q4 2023 Feb 08, 2024	SELL	$100.18 - $109.02 $1.17 Million - $1.27 Million	-11,695 Reduced 15.39%	64,272 $7.01 Million
Q3 2023 Oct 24, 2023	SELL	$102.95 - $114.33 $382,047 - $424,278	-3,711 Reduced 4.66%	75,967 $7.82 Million
Q2 2023 Jul 28, 2023	BUY	$108.61 - $118.38 $561,622 - $612,142	5,171 Added 6.94%	79,678 $9.19 Million
Q1 2023 May 12, 2023	BUY	$102.94 - $114.86 $88,116 - $98,320	856 Added 1.16%	74,507 $7.93 Million
Q4 2022 Feb 13, 2023	BUY	$87.44 - $112.11 $1.02 Million - $1.31 Million	11,670 Added 18.83%	73,651 $8.17 Million
Q3 2022 Nov 04, 2022	BUY	$84.53 - $94.96 $331,188 - $372,053	3,918 Added 6.75%	61,981 $5.34 Million
Q2 2022 Aug 04, 2022	BUY	$83.49 - $94.64 $319,015 - $361,619	3,821 Added 7.04%	58,063 $5.29 Million
Q1 2022 May 06, 2022	BUY	$73.51 - $82.4 $32,638 - $36,585	444 Added 0.83%	54,242 $4.45 Million
Q4 2021 Feb 11, 2022	BUY	$72.28 - $90.54 $38,742 - $48,529	536 Added 1.01%	53,798 $4.12 Million
Q3 2021 Nov 01, 2021	BUY	$71.68 - $78.83 $346,142 - $380,670	4,829 Added 9.97%	53,262 $4 Million
Q2 2021 Aug 12, 2021	BUY	$70.31 - $77.77 $693,889 - $767,512	9,869 Added 25.59%	48,433 $3.77 Million
Q1 2021 May 14, 2021	SELL	$68.86 - $81.11 $126,633 - $149,161	-1,839 Reduced 4.55%	38,564 $2.97 Million
Q4 2020 Feb 11, 2021	SELL	$71.77 - $79.65 $76,363 - $84,747	-1,064 Reduced 2.57%	40,403 $3.31 Million
Q3 2020 Nov 04, 2020	BUY	$73.18 - $82.95 $326,090 - $369,625	4,456 Added 12.04%	41,467 $3.44 Million
Q2 2020 Aug 06, 2020	SELL	$70.42 - $80.13 $427,026 - $485,908	-6,064 Reduced 14.08%	37,011 $2.86 Million
Q1 2020 May 14, 2020	BUY	$63.36 - $87.82 $53,222 - $73,768	840 Added 1.99%	43,075 $3.31 Million
Q4 2019 Feb 07, 2020	BUY	$77.58 - $87.54 $407,217 - $459,497	5,249 Added 14.19%	42,235 $3.84 Million
Q3 2019 Nov 12, 2019	BUY	$76.08 - $82.93 $13,466 - $14,678	177 Added 0.48%	36,986 $3.11 Million
Q2 2019 Aug 12, 2019	SELL	$69.84 - $81.59 $469,254 - $548,203	-6,719 Reduced 15.44%	36,809 $2.84 Million
Q1 2019 May 07, 2019	BUY	$69.58 - $79.36 $832,803 - $949,859	11,969 Added 37.93%	43,528 $3.62 Million
Q4 2018 Feb 12, 2019	BUY	$65.24 - $75.71 $449,438 - $521,566	6,889 Added 27.92%	31,559 $2.41 Million
Q3 2018 Nov 13, 2018	BUY	$57.69 - $67.84 $71,593 - $84,189	1,241 Added 5.3%	24,670 $1.75 Million
Q2 2018 Aug 08, 2018	BUY	$50.83 - $59.72 $15,198 - $17,856	299 Added 1.29%	23,429 $1.41 Million
Q1 2018 May 15, 2018	SELL	$50.96 - $59.23 $618,144 - $718,459	-12,130 Reduced 34.4%	23,130 $1.23 Million
Q4 2017 Feb 14, 2018	BUY	$51.62 - $61.64 $124,094 - $148,182	2,404 Added 7.32%	35,260 $2 Million
Q3 2017 Nov 15, 2017	BUY	$58.67 - $63.13 $170,201 - $183,140	2,901 Added 9.68%	32,856 $2.11 Million
Q2 2017 Aug 14, 2017	BUY	N/A	29,955	29,955 $1.88 Million

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Independent Advisor Alliance, based on Form 13F filings with the SEC.

News

Stay updated on Independent Advisor Alliance with notifications on news.

Account

Independent Advisor Alliance Merck & Co., Inc. Transaction History